State Attorney General Probes Off-Label Actiq Use

Law360, New York (November 22, 2006, 12:00 AM EST) -- Actiq, the highly addictive treatment for cancer pain that looks like a lollypop, is being illegally pushed by manufacturer Cephalon Inc. for uses not approved by the U.S. Food and Drug Administration, according to the Connecticut Attorney General.

Attorney General Richard Blumenthal told the Wall Street Journal that a two-year-old investigation confirmed his office’s suspicions—that Cephalon markets the controversial narcotic to far more doctors than it is approved for.

Cephalon markets the drug to sports-medicine specialists, family practitioners and others, giving the doctors coupons for free...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.